SEIJI / OBSERVATORY 01

SEIJI

SEIJI

Skincare developed from regenerative science.

SEIJI / PRODUCTS

Minimum steps. Maximum care.

Only what your skin needs

01 TREATMENT MASK

02 CLEANSING OIL

03 CLEANSING CREAM

Yarrow Mask
Yarrow Mask

SEIJI / 01 · SATURATE. SOOTHE. RESTORE.

Yarrow Mask

BC YARROW / SINGLE USE / 10–15 MIN

IN DEVELOPMENT

Yarrow Cleansing Oil
Yarrow Cleansing Oil

SEIJI / 02 · DISSOLVE. EMULSIFY. RINSE.

Yarrow Cleansing Oil

BC YARROW / BOTANICAL CLEANSING OIL

IN DEVELOPMENT

Yarrow Cleansing Cream
Yarrow Cleansing Cream

SEIJI / 03 · LATHER. LIFT. RINSE.

Cleansing Cream


BC YARROW / CREAM CLEANSER

IN DEVELOPMENT

THE SCIENCE OF SEIJI

THE SCIENCE OF SEIJI

RESEARCH RECORD / 2026

Our research focuses on active molecule development, ingredient performance, formulation optimization, and cosmetic delivery systems.

We study how new actives interact with skin biology, how leading Korean formulations achieve high performance, and how ingredient combinations can be optimized for stability, absorption, texture, and efficacy.

The goal is to translate molecular research and advanced cosmetic formulation science into better-performing skincare.

01 FORMULATION

Research into formulation architecture, ingredient interaction, texture, pH, emulsification, stability and delivery.

FORMULATION ARCHITECTURE
TEXTURE + VISCOSITY
pH OPTIMIZATION
EMULSIFICATION
DELIVERY SYSTEMS

02 INGREDIENTS

Evaluation of botanical extracts, cosmetic actives and emerging molecular technologies based on function, compatibility and scientific evidence.

BOTANICAL EXTRACTS
ACTIVE MOLECULES
HUMECTANTS
ANTIOXIDANTS
BARRIER SUPPORT
BC YARROW / ACHILLEA MILLEFOLIUM

03 PRODUCTION + VALIDATION

Translating research into stable, manufacturable cosmetic systems through prototyping, testing and production optimization.

PROTOTYPING
STABILITY
MICROBIOLOGY
PACKAGING COMPATIBILITY
SCALE-UP

RESEARCH → FORMULATION → PROTOTYPE → VALIDATION → PRODUCTION

Future of SEIJI

SEIJI

04 Anti-Aging Cream

IN DEVELOPMENT

A future anti-aging treatment currently progressing through molecular research, safety and formulation development.

LONG-TERM R&D / S-001

+

MOLECULAR RESEARCH

Development Timeline

Development Timeline

2026

Molecule Identified

+

2026

Molecule Identified

+

SEP 2026

SEP 2026

Initial In Vitro Results

Early biological testing completed. Initial results supported further investigation in inflammation-stressed adipose tissue models.

Early biological testing completed. Initial results supported further investigation in inflammation-stressed adipose tissue models.

CURRENT

Q4 2026

Batch Production + Toxicology

+

Q4 2026

Batch Production + Toxicology

+

Q1 2027

Expanded Production + Formulation Development

+

Q1 2027

Expanded Production + Formulation Development

+

Q2–Q3 2027

Scale-Up Preparation

+

Q2–Q3 2027

Scale-Up Preparation

+

Q3–Q4 2027

Human Trial / Proof of Concept

+

Q3–Q4 2027

Human Trial / Proof of Concept

+

2028

Commercialization

+

2028

Commercialization

+

SEIJI 04 / CURRENTLY IN DEVELOPMENT / NOT YET AVAILABLE

THE SEIJI JOURNAL

001

01.09.26

SEIJI

SEIJI

SEIJI

FIELD NOTES / OCCASIONAL CORRESPONDENCE

VANCOUVER / CANADA

INSTAGRAM

PRIVACY

TERMS

© 2026 SEIJI LABORATOIRE.